Effects of SDZ NVI-085, a putative subtype-selective α1-agonist, on canine cataplexy, a disorder of rapid eye movement sleep
- 19 November 1991
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 205 (1) , 11-16
- https://doi.org/10.1016/0014-2999(91)90763-g
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The role of α1-adrenoceptor subtypes in the regulation of arterial blood pressureEuropean Journal of Pharmacology, 1990
- Central α1 adrenoceptor subtypes in narcolepsy-cataplexy: a disorder of REM sleepBrain Research, 1989
- (+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of α1-adrenoceptorsEuropean Journal of Pharmacology: Molecular Pharmacology, 1989
- Evidence for multiple [ 3H]prazosin binding sites in canine brain membranesBrain Research, 1989
- Role of central alpha-1 adrenoceptors in canine narcolepsy.Journal of Clinical Investigation, 1988
- 5-Methyl-urapidil discriminates between subtypes of the α1-adrenoceptorEuropean Journal of Pharmacology, 1988
- α1Adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca2+ in smooth muscleNature, 1987
- Identification of subtypes of [3H]prazosin-labelledEuropean Journal of Pharmacology, 1985